HAIR STYLING PATENTS FOR 2006 - Patent and Intellectual ...

www.FormulaScan.com - Patents listed by Formula Scan were retrieved by parsing the claims in the original documents.
Our lists have greater than 95% relevance to the subject
cancer a composition in an amount effective to treat cancer, prevent cancer or delay the progression
of cancer in the animal or the human. The composition comprises a pharmaceutically acceptable
excipient, and ascorbate which is joined to a carrier structure containing an anti-cancer active agent,
said carrier structure being capable of releasing the anti-cancer agent in the presence of a reactive
oxygen species.
Appl: 20080279901
Composition comprising encapsulated silicone compounds
The present invention relates to a cosmetic composition intended for the care and/or make-up of
keratinous substance(s) comprising, in a physiologically acceptable medium, at least one compound
X, one compound Y and at least one catalyst, with at least one of the compounds X or Y being a
polyorganosiloxane, and said compounds X and Y being capable of reacting together by a
hydrosilylation reaction in the presence of a catalyst, with at least one compound from the
compounds X and Y being present in said composition in an encapsulated form, said catalyst being
combined with at least one of said encapsulated compound X or Y.
Appl: 20080292681
Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative
Damage
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or
eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of
processes that involve associated oxidative damage. In particular, it is for the treatment of processes
associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis,
with oxidative damage to DNA and with physical exercise.
Appl: 20080292703
Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical
Conjugation, and Their Use in the Pharmaceutical Field
The present invention describes a new group of bioconjugates which can be obtained by means of
indirect synthesis, via a molecular spacer, between hyaluronic acid and/or its derivatives and drugs
with an antitumoral activity belonging to different groups, their preparation process and use in the
oncological field. The new derivatives, in relation to the type of bond and Substitution degree, have
This document was prepared by www.FormulaScan.com. Its reproduction in any type of form or format is strictly prohibited without
the written consent of Formula Scan